A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

504

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

March 31, 2004

Conditions
Pneumonia
Interventions
DRUG

clarithromycin extended release (ER)

7 days of clarithromycin extended release (ER), 1.0 g by mouth once daily

DRUG

azithromycin SR

Single, 2.0 g oral dose of azithromycin sustained release (SR) by mouth once daily

Trial Locations (72)

1427

Pfizer Investigational Site, Buenos Aires

10617

Pfizer Investigational Site, Tallinn

13419

Pfizer Investigational Site, Tallinn

13619

Pfizer Investigational Site, Tallinn

27012

Pfizer Investigational Site, Clemmons

27103

Pfizer Investigational Site, Winston-Salem

28144

Pfizer Investigational Site, Salisbury

29406

Pfizer Investigational Site, Charleston

29485

Pfizer Investigational Site, Summerville

32806

Pfizer Investigational Site, Orlando

35215

Pfizer Investigational Site, Birmingham

35242

Pfizer Investigational Site, Birmingham

35565

Pfizer Investigational Site, Haleyville

36078

Pfizer Investigational Site, Tallassee

36106

Pfizer Investigational Site, Montgomery

36109

Pfizer Investigational Site, Montgomery

38358

Pfizer Investigational Site, Milan

51014

Pfizer Investigational Site, Tartu

59701

Pfizer Investigational Site, Butte

70043

Pfizer Investigational Site, Chalmette

70112

Pfizer Investigational Site, New Orleans

70128

Pfizer Investigational Site, New Orleans

82601

Pfizer Investigational Site, Casper

83642

Pfizer Investigational Site, Meridian

83651

Pfizer Investigational Site, Nampa

83703

Pfizer Investigational Site, Boise

83704

Pfizer Investigational Site, Boise

83706

Pfizer Investigational Site, Boise

83709

Pfizer Investigational Site, Boise

83713

Pfizer Investigational Site, Boise

84088

Pfizer Investigational Site, West Jordan

84102

Pfizer Investigational Site, Salt Lake City

84109

Pfizer Investigational Site, Salt Lake City

84118

Pfizer Investigational Site, Taylorsville

84121

Pfizer Investigational Site, Salt Lake City

85014

Pfizer Investigational Site, Phoenix

85201

Pfizer Investigational Site, Mesa

85282

Pfizer Investigational Site, Tempe

92037

Pfizer Investigational Site, La Jolla

92128

Pfizer Investigational Site, San Diego

105077

Pfizer Investigational Site, Moscow

105229

Pfizer Investigational Site, Moscow

107066

Pfizer Investigational Site, Moscow

119048

Pfizer Investigational Site, Moscow

214019

Pfizer Investigational Site, Smolensk

07733

Pfizer Investigational Site, Holmdel

B7000AXD

Pfizer Investigational Site, Tandil

C1120AAF

Pfizer Investigational Site, Buenos Aires

C1272AAA

Pfizer Investigational Site, Buenos Aires

C1282AFQ

Pfizer Investigational Site, Buenos Aires

T5A 4L8

Pfizer Investigational Site, Edmonton

V3K 3P4

Pfizer Investigational Site, Coquitlam

A1E 2E2

Pfizer Investigational Site, St. John's

M9W 4L6

Pfizer Investigational Site, Toronto

G7H 5H6

Pfizer Investigational Site, Chicoutimi

J2B 1H8

Pfizer Investigational Site, Drummondville

J2G 8Z9

Pfizer Investigational Site, Granby

J4N 1E1

Pfizer Investigational Site, Longueuil

H9R 4S3

Pfizer Investigational Site, Pointe-Claire

J7Z 5T3

Pfizer Investigational Site, Saint-Jérôme

G1V 4G5

Pfizer Investigational Site, Ste-Foy

S7K 3H3

Pfizer Investigational Site, Saskatoon

500 033

Pfizer Investigational Site, Hyderabad

560 034

Pfizer Investigational Site, Bangalore

682 026

Pfizer Investigational Site, Elamakkara, Cochin

411 053

Pfizer Investigational Site, Pune

141 001

Pfizer Investigational Site, Ludhiana

641 022

Pfizer Investigational Site, Coimbatore

LT-3000

Pfizer Investigational Site, Kaunas

LT-2010

Pfizer Investigational Site, Vilnius

Unknown

Pfizer Investigational Site, Moscow

Pfizer Investigational Site

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY